Jazz Pharmaceuticals plc (JAZZ) Capital expenditures 2016–2025
Jazz Pharmaceuticals plc (JAZZ) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$58.8MFY2025 · since FY2016: $9.7M → $58.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $58.8M | +54.3% |
| FY2024 | $38.1M | +58.9% |
| FY2023 | $24.0M | -17.5% |
| FY2022 | $29.0M | +5.1% |
| FY2021 | $27.6M | +84.2% |
| FY2020 | $15.0M | -62.6% |
| FY2019 | $40.1M | +97.0% |
| FY2018 | $20.4M | -29.6% |
| FY2017 | $28.9M | +198.9% |
| FY2016 | $9.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice